Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Is endothelial dysfunction reversible?

R E Schmieder1, H P Schobel

  • 1Department of Medicine IV, University Erlangen-Nürnberg, Würnberg, Germany.

The American Journal of Cardiology
|July 13, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effect of empagliflozin on ketone bodies in patients with stable chronic heart failure.

Cardiovascular diabetology·2021
Same author

[Comments on the guidelines (2018) of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH) on the management of arterial hypertension].

Der Internist·2019
Same author

[European guidelines for the management of arterial hypertension 2018-what has changed?]

Der Internist·2019
Same author

SGLT-2-inhibition with dapagliflozin reduces tissue sodium content: a randomised controlled trial.

Cardiovascular diabetology·2018
Same author

Reply to comment on Cost of poor adherence to anti-hypertensive therapy in five European country.

The European journal of health economics : HEPAC : health economics in prevention and care·2015
Same author

Low resting heart rates are associated with new-onset atrial fibrillation in patients with vascular disease: results of the ONTARGET/TRANSCEND studies.

Journal of internal medicine·2015
Same journal

Real-World Effectiveness and Tolerability of Sacubitril/Valsartan in Octogenarian Patients With Heart Failure: Results From the PARACHUTER Study.

The American journal of cardiology·2026
Same journal

ECG-Guided Conduction Pathways as a Lever to Shorten Post-TAVI Hospitalization.

The American journal of cardiology·2026
Same journal

Cystatin-C versus creatinine and kidney function in heart failure with preserved ejection fraction: a SOGALDI-PEF analysis.

The American journal of cardiology·2026
Same journal

Balloon-expandable versus Self-expanding Valves in Patients with Small Aortic Annuli Undergoing Transcatheter Aortic Valve Replacement.

The American journal of cardiology·2026
Same journal

Drug-Coated Balloons versus Drug-Eluting Stents following Coronary Atherectomy in Severely Calcified Lesions: A Systematic Review and Meta-Analysis.

The American journal of cardiology·2026
Same journal

Prehospital Statin Therapy and Outcomes in ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.

The American journal of cardiology·2026
See all related articles

Chronic antihypertensive therapy does not restore endothelial function in essential hypertension. However, lipid-lowering therapy effectively restores endothelial function in hypercholesterolemia, with full recovery potentially taking over a year.

Area of Science:

  • Cardiovascular Medicine
  • Pharmacology

Background:

  • Limited data exists on therapy's impact on endothelial function in hypertension and hypercholesterolemia.
  • Chronic antihypertensive therapy's effect on endothelial function in essential hypertension remains unproven.

Purpose of the Study:

  • To evaluate the efficacy of chronic therapies in restoring endothelial function.
  • To compare the effects of antihypertensive and lipid-lowering treatments on vascular health.

Main Methods:

  • Review of existing literature on endothelial function in treated essential hypertension and hypercholesterolemia.
  • Analysis of studies examining therapy duration and endothelial function recovery.

Main Results:

  • Antihypertensive therapy has not demonstrated restoration of endothelial function in essential hypertension.

Related Experiment Videos

  • Lipid-lowering therapy, such as with fluvastatin, effectively restores endothelial function in hypercholesterolemia.
  • Beneficial effects observed within 3 months, with full restoration potentially exceeding 1 year.

    • Conclusions:

    • Lipid-lowering therapy offers a viable strategy for improving endothelial function in hypercholesterolemia.
    • Further research is needed to establish effective antihypertensive strategies for endothelial function.